Literature DB >> 15054609

Tumour growth inhibition of human pancreatic cancer xenografts in SCID mice by cimetidine.

O Sürücü1, M Middeke, I Höschele, J Kalder, S Hennig, C Dietz, I Celik.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15054609     DOI： 10.1007/s00011-003-0318-1

Source DB:  PubMed          Journal:  Inflamm Res        ISSN： 1023-3830            Impact factor:   4.575


× No keyword cloud information.
  4 in total

1.  Discovery and preclinical validation of drug indications using compendia of public gene expression data.

Authors:  Marina Sirota; Joel T Dudley; Jeewon Kim; Annie P Chiang; Alex A Morgan; Alejandro Sweet-Cordero; Julien Sage; Atul J Butte
Journal:  Sci Transl Med       Date:  2011-08-17       Impact factor: 17.956

2.  Targeting mitochondrial STAT3 with the novel phospho-valproic acid (MDC-1112) inhibits pancreatic cancer growth in mice.

Authors:  Gerardo G Mackenzie; Liqun Huang; Ninche Alston; Nengtai Ouyang; Kvetoslava Vrankova; George Mattheolabakis; Panayiotis P Constantinides; Basil Rigas
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

3.  EHR-based phenome wide association study in pancreatic cancer.

Authors:  Tomasz Adamusiak; Mary Shimoyama
Journal:  AMIA Jt Summits Transl Sci Proc       Date:  2014-04-07

4.  Repurposing drugs in oncology (ReDO)-cimetidine as an anti-cancer agent.

Authors:  Pan Pantziarka; Gauthier Bouche; Lydie Meheus; Vidula Sukhatme; Vikas P Sukhatme
Journal:  Ecancermedicalscience       Date:  2014-11-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.